MANGROVE PARTNERS IM, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001535392
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2024 · 160 positions · Total reported value $1.15B · Top-10 concentration 33.8% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 69.6% · 143 new · 48 cut · 205 exited
Active Share (vs S&P 500): 99.2% · vs QQQ: 99.6% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -8.2% · vs SPY -10.3% · Prev Value $1.52B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +4.0% · vs SPY +1.8% · Latest Value $1.47B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2024 13F filing, MANGROVE PARTNERS IM, LLC disclosed 160 equity positions with a combined reported value of $1.15B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 33.8% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.
The largest disclosed positions as of Q3 2024 were ATMU ($44.36M), MBC ($42.95M), LBRDK ($41.08M). By sector, the heaviest allocations are Consumer Discretionary 19.8%, Health Care 18.7%. Versus the prior quarter, allocation shifted toward Health Care (+6.7pp), Consumer Discretionary (+4.2pp) and away from Industrials (-2.1pp), Consumer Staples (-3.3pp).
Versus the prior quarter, MANGROVE PARTNERS IM, LLC opened 143 new positions, trimmed 48 and fully exited 205, a turnover rate of 69.6% of positions. The portfolio's overlap with the prior quarter was 49% of names.
The largest new positions opened in Q3 2024 were KROS ($16.67M), INDV ($11.27M), CEP ($4.51M).
Of the 205 positions fully exited versus the prior quarter, the largest were ACI ($42.23M), X ($41.17M), DFS ($35.16M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2024)
- KROS KEROS THERAPEUTICS INC · $16.67M
- INDV INDIVIOR PHARMACEUTICALS INC · $11.27M
- CEP CANTOR EQUITY PARTNERS INC · $4.51M
- DTSQU DT CLOUD STAR ACQUISITION CO · $2.61M
- FVNNU FUTURE VISION II ACQUISITION · $2.45M
- CAPNU CAYSON ACQUISITION CORP · $2.00M
- VACHU VOYAGER ACQUISITION CORP · $1.76M
- YHNAU YHN ACQUISITION I LTD · $1.71M
Fully Exited (vs previous quarter)
- ACI ALBERTSONS COMPANIES INC · prev qtr: $42.23M
- X UNITED STATES STL CORP NEW · prev qtr: $41.17M
- DFS DISCOVER FINL SVCS · prev qtr: $35.16M
- EMBJ EMBRAER S.A. · prev qtr: $33.39M
- CTLT CATALENT INC · prev qtr: $25.98M
- AMED AMEDISYS INC · prev qtr: $24.31M
- MCACW MONTEREY CAP ACQUISITION COR · prev qtr: $14.47M
- AOGOW Arogo Capital Acquisition Corp · prev qtr: $10.43M
Insider Transactions (Form 4)
Latest MANGROVE PARTNERS IM, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Mangrove Partners IM is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 426 US equity positions with a combined value of $1.52B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: GREENWICH, CT, United States
- SEC registration: 801-78070 (status: Approved), registered 2013-05-20
- Regulatory AUM (Form ADV): $2.71B as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
- Website: mangrovepartners.com
Portfolio Structure
- 426 positions · $1.52B reported value (Q2 2026)
- Top 10 holdings = 38.1% of reported value
- Largest position: INDV (INDIVIOR PHARMACEUTICALS INC) at 7.2%
- Average position size: $3.57M
Sector Tilt
- Consumer Discretionary 20.8%
- Financials 18.5%
- Information Technology 13.9%
- (classified holdings cover 89% of value)
Quarterly Activity
- Q2 2026: 198 new, 40 added, 61 reduced, 199 exited
- 127 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.18M | $44.36M | 3.86% | Reduce | |
| 2 |
|
2.32M | $42.95M | 3.74% | Reduce | |
| 3 |
|
531.55K | $41.08M | 3.58% | Add | |
| 4 |
|
2.15M | $38.69M | 3.37% | Reduce | |
| 5 |
|
456.58K | $38.26M | 3.33% | Reduce | |
| 6 |
|
410.63K | $37.46M | 3.26% | Reduce | |
| 7 |
|
1.03M | $37.20M | 3.24% | Hold | |
| 8 |
|
813.04K | $35.99M | 3.13% | Hold | |
| 9 |
|
8.73M | $35.88M | 3.12% | Hold | |
| 10 |
|
378.78K | $35.88M | 3.12% | Reduce | |
| 11 |
|
990.77K | $33.70M | 2.93% | Reduce | |
| 12 |
|
2.00M | $33.24M | 2.89% | Hold | |
| 13 |
|
636.12K | $32.65M | 2.84% | Add | |
| 14 |
|
1.53M | $32.57M | 2.83% | Add | |
| 15 |
|
392.06K | $29.09M | 2.53% | Hold | |
| 16 |
|
223.30K | $26.12M | 2.27% | Hold | |
| 17 |
|
419.90K | $23.41M | 2.04% | Hold | |
| 18 |
|
689.52K | $23.10M | 2.01% | Hold | |
| 19 |
|
1.15M | $22.21M | 1.93% | Hold | |
| 20 |
|
194.71K | $21.37M | 1.86% | Add | |
| 21 |
|
659.55K | $20.39M | 1.77% | Hold | |
| 22 |
|
439.31K | $19.77M | 1.72% | Hold | |
| 23 |
|
338.64K | $18.23M | 1.59% | Hold | |
| 24 |
|
249.49K | $17.76M | 1.55% | Hold | |
| 25 |
|
318.77K | $17.40M | 1.51% | Hold | |
| 26 |
|
287.00K | $16.67M | 1.45% | New | |
| 27 |
|
2.82M | $16.67M | 1.45% | Hold | |
| 28 |
|
434.32K | $15.69M | 1.37% | Hold | |
| 29 |
|
493.06K | $15.48M | 1.35% | Add | |
| 30 |
|
1.16M | $11.27M | 0.98% | New | |
| 31 |
|
951.09K | $10.89M | 0.95% | Hold | |
| 32 |
|
950.00K | $10.77M | 0.94% | Hold | |
| 33 |
|
950.10K | $10.68M | 0.93% | Hold | |
| 34 |
|
896.70K | $10.17M | 0.89% | Hold | |
| 35 |
|
904.00K | $10.00M | 0.87% | Hold | |
| 36 |
|
459.63K | $9.88M | 0.86% | Hold | |
| 37 |
|
4.60M | $9.48M | 0.82% | Reduce | |
| 38 |
|
681.03K | $9.00M | 0.78% | Hold | |
| 39 |
|
1.23M | $8.83M | 0.77% | Hold | |
| 40 |
|
1.38M | $8.53M | 0.74% | Hold | |
| 41 |
|
750.00K | $8.45M | 0.73% | Hold | |
| 42 |
|
502.27K | $8.24M | 0.72% | Reduce | |
| 43 |
|
650.00K | $7.54M | 0.66% | Hold | |
| 44 |
|
1.33M | $7.25M | 0.63% | Hold | |
| 45 |
|
625.00K | $7.19M | 0.63% | Hold | |
| 46 |
|
385.41K | $7.01M | 0.61% | Hold | |
| 47 |
|
607.68K | $6.75M | 0.59% | Hold | |
| 48 |
|
5.58M | $6.64M | 0.58% | Hold | |
| 49 |
|
500.00K | $5.95M | 0.52% | Hold | |
| 50 |
|
482.59K | $5.88M | 0.51% | Hold | |
FAQ
What did MANGROVE PARTNERS IM, LLC buy in 2024-Q3?
In its 2024-Q3 13F filing, MANGROVE PARTNERS IM, LLC reported 160 equity positions worth $1.15B in aggregate; its largest disclosed positions were ATMU ($44.36M), MBC ($42.95M), LBRDK ($41.08M).
How large is MANGROVE PARTNERS IM, LLC's portfolio?
MANGROVE PARTNERS IM, LLC reported $1.15B of long equity holdings across 160 positions as of 2024-Q3. Top-10 holdings account for 33.8% of reported value.
What is MANGROVE PARTNERS IM, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.